🇺🇸 FDA

Drug profile · INN

pasireotide diaspartate

SIGNIFOR

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

pasireotide diaspartate (SIGNIFOR) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.

Key facts

INN pasireotide diaspartate
Brand SIGNIFOR
Route SUBCUTANEOUS
Formulation SOLUTION

Frequently asked questions

What is pasireotide diaspartate?

pasireotide diaspartate (SIGNIFOR) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.

What is the brand name for pasireotide diaspartate?

SIGNIFOR is a marketed brand name for pasireotide diaspartate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of pasireotide diaspartate?

pasireotide diaspartate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.